adjuvant avelumab versus control does not significantly improve dfs but does improve os in high-...
Published 4 months ago • 19 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
2:53
adjuvant pembrolizumab vs placebo for dfs benefit in rcc
-
27:18
adjuvant and neoadjuvant dilemmas
-
2:13
adjuvant nivolumab as soc for high-risk muscle-invasive urothelial carcinoma after radical resection
-
1:39
phase ib trial of bintrafusp alfa for advanced urothelial cancer
-
1:33
ambassador: extended dfs follow-up of adjuvant pembrolizumab in miuc
-
2:22
adjuvant ipilimumab versus high-dose interferon for resected melanoma
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
6:40
first randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: the adjuvo study.
-
59:18
brain on fire & other lessons of autoimmune encephalitis - pavel repovic, md
-
4:45
combi-ad trial: adjuvant dabrafenib plus trametinib in patients with resected stage iii braf v60...
-
2:59
ambassador: adjuvant pembrolizumab in muscle-invasive urothelial carcinoma
-
5:35
evaluation of immune responses using adjuvant α-tocopherol in acute and chronic phases of tr...
-
1:10
updated efficacy results for avelumab in metastatic urothelial carcinoma
-
0:39
mohamad e. allaf, md, on helping non-metastatic renal cell carcinoma patients with adjuvant therapy
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
7:13
hcc: the criteria for adjuvant therapy
-
7:11
avelumab in combinations for lung cancer and update from alex study
-
48:44
fda-mra approaches to neoadjuvant treatment in melanoma: session 2
-
0:35
adjuvo: first randomized trial of adjuvant mitotane in adrenocortical carcinoma patients
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
1:49
dr. daver on results of a combination study with azacitidine/nivolumab in aml